Ran Frenkel
Overview
Ran Frenkel received an average of $4M in total compensation, including $247K in salary, at Karyopharm Therapeutics between 2014 and 2021.
Source: SEC filings on April 8, 2022 and April 7, 2015.
Related executives
We found ten more executives who work or worked at Karyopharm Therapeutics.
Richard Paulson
Karyopharm Therapeutics
Chief Executive Officer
Sharon Shacham
Karyopharm Therapeutics
Chief Scientific Officer
Michael Kauffman
Karyopharm Therapeutics
Chief Executive Officer
Michael Mason
Karyopharm Therapeutics
Chief Financial Officer
Jatin Shah
Karyopharm Therapeutics
Chief Medical Officer
Christopher Primiano
Karyopharm Therapeutics
General Counsel
Anand Varadan
Karyopharm Therapeutics
Executive Vice President, Chief Commercial Officer
Michael MSM
Karyopharm Therapeutics